BacSp222 is a recently discovered peptide bacteriocin produced by the opportunistic pet pathogen Staphylococcus pseudintermedius strain 222. This bacteriocin kills a wide range of Gram-positive bacteria, allowing producer cells to eliminate competing bacterial strains residing in the same physiological niche of the infected host organism. Research on BacSp222 to date has mainly focused on the molecular biology of the peptide, on the physicochemical mechanism of its action against bacterial membranes, and on determining the structure of the peptide using nuclear magnetic resonance (NMR) technique. Nevertheless, the most intriguing results proved that the described bacteriocin is not only capable of killing bacteria, but also shows significant activity against host cells. At higher doses, the peptide has a cytotoxic effect, while at very low concentrations (nanomoles/l) it acts as an immunomodulatory pro-inflammatory factor, inducing in model macrophage cell lines the activity of nitric oxide synthase (iNOs) and stimulating TNF secretion. A second intriguing finding revealed that the bacteriocin BacSp222 is produced and secreted along with several post-translationally modified isoforms, identified as succinic acid derivatives. Regarding these preliminary results, the presented project is devoted to extensive studies on the immunomodulatory effect of bacteriocin on eukaryotic cells, on the identification of cellular receptors and possible cytokines involved in this phenomenon, as well as on the mechanism of formation of the mentioned post-translational modifications, their influence on the biological activity of bacteriocin and the structure of its molecule.
Comprehensive studies on immunomodulatory activity of BacSp222 bacteriocin will be conducted using model cell lines and primary cells. Native bacteriocin and bacteriocin after removal of N-terminal formyl-methionine will be used to verify the effect of formylation on recognition by specific receptors. Analysis of cytokines or growth factors produced by cells after exposure to bacteriocin will be carried out using the LUMINEX platform, studies on the induction of iNOs will be conducted by direct measurements of enzyme activity in cells, as well as based on measurements of enzyme gene expression by RT-PCR. Identification of cellular receptors involved in bacteriocin recognition will be performed using co-stimulation of cells with bacteriocin and receptor-specific antagonistic compounds, by measuring secretion of specific cytokines, by measuring intracellular mobilization of cAMP or Ca+2, and/or using modified cell lines exposing specific cellular recombinant receptors. Determinations of the effects of bacteriocin on transcription factors (e.g., AP-1, NFκB) will be performed using the electrophoretic EMSA technique. Effects of bacteriocin on cell morphology and verification of internalization of bacteriocin into cells will be studied by confocal microscopy, fluorescently labeled peptide and/or immunochemical techniques. Studies on the post-translational regulation of bacteriocin biological activity will be conducted using modified isoforms of the peptide isolated from culture medium. The effect of succinylation on the structure of the peptide in solution will be determined by NMR technique, the biological properties of the isoforms will be determined by bactericidal and cytotoxic activity assays, as well as by cell biochemistry research techniques described above. The mechanism of post-translational processing of bacteriocin and the influence of environmental factors on this phenomenon will be studied by chromatographic techniques.
Biologically, bacteriocins are defined as peptides or proteins produced by bacteria on ribosomes, capable of killing closely related strains living in the same physiological or ecological niche. These molecules also act as regulators of metabolism dependent on population density or the presence of other bacteria. It is estimated that 99% of bacterial strains produce at least one bacteriocin, so the biological and ecological importance of these factors is enormous. Moreover, bacteriocins or bacteriocin-producing microorganisms are widely used in the food industry, feed production, veterinary medicine and medicine. The realization of the research presented in this project will first of all allow to determine whether bacteriocins produced by opportunistic pathogens can also play a role of virulence factors, able to modulate the activity of immune cells of the infected organism. In addition, it will also allow to investigate a new post-translational mechanism of regulation of the of the biological activity of bacteriocins, based on polypeptide chain succinylation.